About Talazoparib Talazoparib is an orally available poly ADP ribose polymerase (PARP) inhibitor .Talazoparib is similar to the…
About Talazoparib Talazoparib is an orally available poly ADP ribose polymerase (PARP) inhibitor .Talazoparib is similar to the…
About Cenobamate Cenobamate works as an anticonvulsant by regulating irregular electrical brain signals. It can be…
About Cenobamate Cenobamate works as an anticonvulsant by regulating irregular electrical brain signals. It can be…
About Cenobamate Cenobamate works as an anticonvulsant by regulating irregular electrical brain signals. It can be…
About Stiripentol Stiripentol is an anticonvulsant medication used for the treatment of Dravet syndrome - a serious genetic brain disorder.…
About Vigabatrin Vigabatrin is used alone or together with other medicines to treat refractory complex partial seizures…
About Acoramidis Acoramidis is a near-complete (>90%) transthyretin stabilizer, developed to mimic the protective properties of the naturally occurring…
About trastuzumab botidotin Trastuzumab botidotin is a differentiated HER2 ADC to treat advanced HER2+ solid tumors. As…
About Ustekinumab Ustekinumab is a monoclonal antibody medication used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,targeting both…
About Infliximab Infliximab, a chimeric monoclonal antibody, is a medication used to treat a number of autoimmune diseases.…
Timolol maleate gel is a topical beta-blocker used to treat superficial infantile hemangiomas by applying it…
About Avatrombopag Avatrombopag is a medication that used for certain conditions that lead to thrombocytopenia (low…
About Nintedanib Nintedanib is an oral medication used for the treatment of idiopathic pulmonary fibrosis and along with other…
About Midostaurin Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic…
About Pacritinib Pacritinib is a medication used to treat adults with intermediate- or high-risk myelofibrosis (MF),…